AXOGEN INC

NASDAQ: AXGN (AxoGen, Inc.)

Last update: 6 days ago, 10:53PM

58.63

7.74 (15.21%)

Previous Close 50.89
Volume 4,412,988
Price / Earnings (Forward) 111.80
Price / Sales 9.85
Price / Book 6.12
52 Weeks Range
23.00 (-60%) — 59.72 (1%)
Profit Margin -3.68%
Operating Margin (TTM) -3.42%
Diluted EPS (TTM) -0.160
Quarterly Revenue Growth (YOY) 17.40%
Total Debt/Equity (MRQ) 67.39%
Current Ratio (MRQ) 4.28
Operating Cash Flow (TTM) 3.62 M
Levered Free Cash Flow (TTM) 2.84 M
Return on Assets (TTM) -0.13%
Return on Equity (TTM) -7.22%

AIStockmoo Score

1.3
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Valuation History info NA
Low debt. Weak profitability. Ample short-term liquidity. Positive cash flow. info
Return on Capital info NA
From our AI technical analysis of the chart. info NA
Uptrend over the past year. Trading near its 52-week high. info
Price and its moving averages are lined up in an uptrend. Its main moving average is flat. Stretched well above its moving average. Volume is heavier on up days. info
Candle Patterns info NA
Above its medium-term trend line. info
No recent price targets, so based on how targets have been revised. info
News Mood info NA
Insider Activity info NA
Institutional Flow info NA
Short Interest info NA
Market environment cautious. info
Sector lagging the market.
Only one pillar has a clear reading, so the score is unchanged.
Price is high against its 52-week average. Up over 5 years. info
Trend up on all three terms. Short-term momentum rising. info
No clear signal from support and resistance. info
Final Score 1.32
Show all

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock AxoGen, Inc. Mixed Bullish

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
AXGN - - - 6.12
UFPT - - - 4.88
NNOX - - - 0.310
QTI - - - 13.92
ESTA - - - 128.59
NMTC - - - 1.80

Select this tab to load the latest available analysis.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Sector Healthcare
Industry Medical Devices
Investment Style Small Growth
% Held by Insiders 4.84%
% Held by Institutions 86.20%

No data within this time range.

No data within this time range.

Recent Signals candle patterns and EMA crosses

▲ Bullish EMA cross 6 sessions ago · 03 Nov
Medium term · EMA 20/50
The 20-day EMA crossed above the 50-day: the medium-term trend turned up.

Technical Setup Medium

Trend order
Slope
Entry –
Volume
Price and its moving averages are lined up in an uptrend. Its main moving average is flat. Stretched well above its moving average. Volume is heavier on up days.
Nearest support: 52.19 – 53.63 · moderate level

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria